Gene expression-based, individualized outcome prediction for surgically treated pancreatic cancer patients

Individualized outcome prediction classifiers were successfully constructed through expression profiling of a total of 8,644 genes in 20 pancreatic cancer cases, which had been consecutively operated. In the study presented here, a consecutively operated, well-defined cohort of 20 pancreatic cancer cases, followed up more than five years, was used to acquire expression profiles of a total of 8,644 unique genes, leading to the successful construction of supervised